Can increased blood viscosity reduce cerebral perfusion and contribute to neurological symptoms and cognitive impairment?

In a 77-year-old, blood-viscosity effects may be particularly consequential when cerebrovascular reserve is reduced by vascular disease or other factors affecting autoregulation. The overall claim is supported for cerebral perfusion and acute neurological manifestations; the link to persistent cognitive impairment remains biologically credible but less directly established.

Cerebral perfusion and neurological effects

• Higher hematocrit and fibrinogen—major determinants of whole-blood viscosity—are associated with lower cerebral blood flow. In polycythemia, reducing hematocrit through treatment or phlebotomy increases cerebral arterial flow velocities, and hemodilution studies similarly show increased cerebral flow after viscosity reduction.
• In acute ischemic stroke, higher whole-blood viscosity independently predicts larger perfusion-deficit and ischemic-core volumes, consistent with reduced tolerance of impaired cerebral circulation.
• Overt hyperviscosity syndrome, particularly IgM-mediated hyperviscosity in Waldenström macroglobulinemia, is clinically associated with headache, dizziness, confusion, imbalance, seizures, and occasionally stroke or coma. Therapeutic plasma exchange lowers plasma viscosity by approximately 20–30% per session and commonly produces rapid symptomatic improvement.

Mechanistic interpretation

• Increased viscosity raises resistance to flow and can slow microvascular transit. Supporting this rheological mechanism, plasma exchange increases nailfold capillary blood-cell velocity in parallel with the fall in plasma viscosity.
• Cerebral autoregulation can compensate for modest changes, but this compensation is less reliable in ischemia or vascular dysfunction. Thus, clinically important effects are most likely in marked erythrocytosis, paraprotein-associated hyperviscosity, or compromised cerebrovascular reserve.

Cognition

• Higher whole-blood viscosity has been associated with lower regional cerebral blood flow in older adults, particularly above roughly 3.95 mPa·s. Separately, lower cerebral perfusion predicted accelerated cognitive decline and incident dementia over 6.9 years in population data.
• Bottom line: Increased viscosity can reduce cerebral perfusion and contribute to acute neurological symptoms. A viscosity–hypoperfusion–cognitive impairment pathway is plausible, but hematocrit and vascular/metabolic factors substantially influence the observed cognitive associations.